Amit Hazan
Stock Analyst at Goldman Sachs
(2.13)
# 2,823
Out of 4,941 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $83.93 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.32 | -65.82% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $2.32 | +718.97% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $14.86 | -46.16% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $50.64 | +24.41% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $194.96 | +39.52% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $13.77 | +23.46% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $12.67 | +3,333.31% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $38.60 | +13.99% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $76.93 | -5.11% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $23.98 | +121.02% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $28.75 | +98.26% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $15.72 | -39.57% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $131.02 | -20.62% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $12.81 | +368.38% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $92.08 | +24.89% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $376.61 | -60.17% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $102.64 | -55.18% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $478.19 | -49.46% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $101.82 | +73.84% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $172.78 | -14.92% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.48 | +163.51% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $83.93
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.32
Upside: -65.82%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $2.32
Upside: +718.97%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $14.86
Upside: -46.16%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $50.64
Upside: +24.41%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $194.96
Upside: +39.52%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $13.77
Upside: +23.46%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $12.67
Upside: +3,333.31%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $38.60
Upside: +13.99%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $76.93
Upside: -5.11%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $23.98
Upside: +121.02%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $28.75
Upside: +98.26%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $15.72
Upside: -39.57%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $131.02
Upside: -20.62%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $12.81
Upside: +368.38%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $92.08
Upside: +24.89%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $376.61
Upside: -60.17%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $102.64
Upside: -55.18%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $478.19
Upside: -49.46%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $101.82
Upside: +73.84%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $172.78
Upside: -14.92%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.48
Upside: +163.51%